GoodRx Holdings, Inc.
corporate_fare Company Profile
GoodRx Holdings, Inc. (NASDAQ:GDRX) is a publicly traded company in the Technology sector. Wiseek has independently scored 13 items for GDRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for GDRX spans 8-K, SCHEDULE 13D/A, 4, 10-Q.
Recent high-impact activity:
- GoodRx Flags Material Weaknesses in Financial Controls, Files 10-Q Late
- GoodRx Restates Q1/Q2 2026 Revenue, Flags Material Weaknesses
- Francisco Partners Converts 7.5M Class B Shares, Sells $9.7M in GoodRx Stock
- Francisco Partners Sells $5.5M GoodRx Stake, Nearly Exits Position
- GoodRx Q2 Revenue Beats, Raises 2026 Outlook on Pharma Direct Surge
Financial Snapshot
Short Interest & Short Volume
3.00 days to coverFINRA reported short interest of 3,574,707 shares in GDRX as of the October 30, 2026 settlement, a 2.7% decrease from the prior period — about 3.0 days to cover at its recent average daily volume. On November 20, 2026, 38.2% of GDRX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.